September 28, 2023
A Delaware federal judge has found numerous patents covering Allergan's bowel treatment drug Viberzi were invalid, handing a win to Sun Pharmaceutical Industries Ltd. and MSN Pharmaceuticals.
November 17, 2022
Drug maker Allergan has largely dropped its patent infringement claims against competitor MSN Pharmaceuticals over a generic version of Allergan's bowel treatment drug Viberzi, according to a Thursday filing.
November 14, 2022
A Delaware federal judge cleared AbbVie unit Allergan on Monday of allegations that it unlawfully used confidential information from Sun Pharmaceuticals to expand its patent suit seeking to block Sun from making generic versions of the irritable bowel syndrome drug Viberzi.
November 03, 2022
A fourth trial kicks off in Austin next week in a multibillion-dollar legal war between VLSI Technology and Intel over the licensing company's microchip technology patents. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.